drugset / Trial / NCT04874324
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349
RandomizedSequentialQuadruple-blindOther
Summary
The present study is planned to assess the safety, tolerability and pharmacokinetic profile of WCK 2349 in US subjects with selected ascending multiple doses of WCK 2349 and to compare the safety, tolerability and pharmacokinetic data with the data observed in similar studies conducted in India.
Timeline
- Start
- 2011-03-17
- Primary completion
- 2011-05-04
- Completion
- 2011-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WCK 2349 | Unknown | 800 mg | Oral |
| Subject | WCK 2349 | Unknown | 1000 mg | Oral |
| Subject | WCK 2349 | Unknown | 1200 mg | Oral |
Indications
No indication recorded.